Dudley Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Dudley Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.58M	Hold	27,476	–	–	0.63%	41
2026 Q1	$1.67M	Hold	27,476	–	–	0.74%	37
2025 Q4	$1.48M	Hold	27,476	–	–	0.64%	40
2025 Q3	$1.24M	Sell	27,476 -646	-2%	-$30.2K	0.56%	44
2025 Q2	$1.3M	Hold	28,122	–	–	0.65%	41
2025 Q1	$1.72M	Hold	28,122	–	–	0.9%	34
2024 Q4	$1.59M	Hold	28,122	–	–	0.8%	35
2024 Q3	$1.46M	Hold	28,122	–	–	0.75%	38
2024 Q2	$1.17M	Sell	28,122 -30	-0.1%	-$1.34K	0.65%	42
2024 Q1	$1.49M	Sell	28,152 -85	-0.3%	-$4.33K	0.87%	30
2023 Q4	$1.45M	Hold	28,237	–	–	0.92%	33
2023 Q3	$1.64M	Hold	28,237	–	–	1.15%	28
2023 Q2	$1.81M	Buy	28,237 +60	+0.2%	+$4.02K	1.21%	26
2023 Q1	$1.95M	Sell	28,177 -50	-0.2%	-$3.53K	1.33%	21
2022 Q4	$2.03M	Buy	+28,227	New	+$2.13M	1.42%	18

Other funds holding BMY

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

ETC

Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Dudley Capital Management's BMY Position: Q2 2026 in Review

Dudley Capital Management held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 27,476 shares worth $1.58M. The position accounts for 0.63% of the portfolio, ranked #41.

Dudley Capital Management first reported a position in BMY in Q4 2022 and has held it in 15 quarters since. The position peaked at $2.03M in Q4 2022. 879 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Dudley Capital Management held 27,476 shares of Bristol-Myers Squibb worth $1.58M as of Q2 2026.
Dudley Capital Management left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 0.63% of Dudley Capital Management's portfolio in Q2 2026, its #41 holding.
Dudley Capital Management first reported a position in Bristol-Myers Squibb in Q4 2022 and has held it in 15 quarters since.
Dudley Capital Management's Bristol-Myers Squibb position peaked at $2.03M in Q4 2022.
879 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Dudley Capital Management's 13F filing for Q2 2026, filed 27 Jul 2026.